JP2022173374A - 経口組成物 - Google Patents
経口組成物 Download PDFInfo
- Publication number
- JP2022173374A JP2022173374A JP2022153423A JP2022153423A JP2022173374A JP 2022173374 A JP2022173374 A JP 2022173374A JP 2022153423 A JP2022153423 A JP 2022153423A JP 2022153423 A JP2022153423 A JP 2022153423A JP 2022173374 A JP2022173374 A JP 2022173374A
- Authority
- JP
- Japan
- Prior art keywords
- present
- salt
- hesperidin
- hihatsu
- muscle
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 61
- AXFYFNCPONWUHW-UHFFFAOYSA-N 3-hydroxyisovaleric acid Chemical compound CC(C)(O)CC(O)=O AXFYFNCPONWUHW-UHFFFAOYSA-N 0.000 claims abstract description 96
- 150000003839 salts Chemical class 0.000 claims abstract description 38
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 claims abstract description 37
- 239000001100 (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)chroman-4-one Substances 0.000 claims abstract description 33
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 claims abstract description 33
- QUQPHWDTPGMPEX-UTWYECKDSA-N aurantiamarin Natural products COc1ccc(cc1O)[C@H]1CC(=O)c2c(O)cc(O[C@@H]3O[C@H](CO[C@@H]4O[C@@H](C)[C@H](O)[C@@H](O)[C@H]4O)[C@@H](O)[C@H](O)[C@H]3O)cc2O1 QUQPHWDTPGMPEX-UTWYECKDSA-N 0.000 claims abstract description 33
- APSNPMVGBGZYAJ-GLOOOPAXSA-N clematine Natural products COc1cc(ccc1O)[C@@H]2CC(=O)c3c(O)cc(O[C@@H]4O[C@H](CO[C@H]5O[C@@H](C)[C@H](O)[C@@H](O)[C@H]5O)[C@@H](O)[C@H](O)[C@H]4O)cc3O2 APSNPMVGBGZYAJ-GLOOOPAXSA-N 0.000 claims abstract description 33
- 229940025878 hesperidin Drugs 0.000 claims abstract description 33
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 claims abstract description 33
- ARGKVCXINMKCAZ-UHFFFAOYSA-N neohesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(CO)O3)OC3C(C(O)C(O)C(C)O3)O)=CC(O)=C2C(=O)C1 ARGKVCXINMKCAZ-UHFFFAOYSA-N 0.000 claims abstract description 33
- 239000000463 material Substances 0.000 claims description 14
- 241000219094 Vitaceae Species 0.000 claims description 11
- 235000021021 grapes Nutrition 0.000 claims description 11
- 240000008574 Capsicum frutescens Species 0.000 claims description 10
- 235000002568 Capsicum frutescens Nutrition 0.000 claims description 7
- 244000273928 Zingiber officinale Species 0.000 claims 1
- 235000006886 Zingiber officinale Nutrition 0.000 claims 1
- 235000008397 ginger Nutrition 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 abstract description 10
- 239000000843 powder Substances 0.000 description 38
- 230000000694 effects Effects 0.000 description 28
- 210000003205 muscle Anatomy 0.000 description 26
- 239000000284 extract Substances 0.000 description 21
- 239000000047 product Substances 0.000 description 20
- 230000008961 swelling Effects 0.000 description 18
- 235000002566 Capsicum Nutrition 0.000 description 16
- 230000006872 improvement Effects 0.000 description 13
- 238000004519 manufacturing process Methods 0.000 description 12
- 239000003826 tablet Substances 0.000 description 12
- 235000005911 diet Nutrition 0.000 description 11
- 230000037213 diet Effects 0.000 description 11
- 239000003814 drug Substances 0.000 description 11
- 239000006002 Pepper Substances 0.000 description 10
- 241000722363 Piper Species 0.000 description 10
- 235000016761 Piper aduncum Nutrition 0.000 description 10
- 235000017804 Piper guineense Nutrition 0.000 description 10
- 235000008184 Piper nigrum Nutrition 0.000 description 10
- 239000008187 granular material Substances 0.000 description 9
- 239000004480 active ingredient Substances 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 8
- 230000004060 metabolic process Effects 0.000 description 8
- 241000219095 Vitis Species 0.000 description 7
- 235000014787 Vitis vinifera Nutrition 0.000 description 7
- 239000007910 chewable tablet Substances 0.000 description 7
- 235000013305 food Nutrition 0.000 description 7
- 238000009472 formulation Methods 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 238000002156 mixing Methods 0.000 description 7
- 230000009467 reduction Effects 0.000 description 7
- 230000001629 suppression Effects 0.000 description 7
- 230000007423 decrease Effects 0.000 description 6
- 235000013402 health food Nutrition 0.000 description 6
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 6
- 238000012423 maintenance Methods 0.000 description 6
- 230000002265 prevention Effects 0.000 description 6
- 239000013589 supplement Substances 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- 235000009754 Vitis X bourquina Nutrition 0.000 description 5
- 235000012333 Vitis X labruscana Nutrition 0.000 description 5
- 229940079593 drug Drugs 0.000 description 5
- 235000013399 edible fruits Nutrition 0.000 description 5
- 239000000314 lubricant Substances 0.000 description 5
- 239000000546 pharmaceutical excipient Substances 0.000 description 5
- -1 rounds Substances 0.000 description 5
- 241000894006 Bacteria Species 0.000 description 4
- 241000758706 Piperaceae Species 0.000 description 4
- 241001593968 Vitis palmata Species 0.000 description 4
- 239000007902 hard capsule Substances 0.000 description 4
- 238000004806 packaging method and process Methods 0.000 description 4
- 239000002245 particle Substances 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 240000004160 Capsicum annuum Species 0.000 description 3
- 235000008534 Capsicum annuum var annuum Nutrition 0.000 description 3
- 206010049565 Muscle fatigue Diseases 0.000 description 3
- 230000002776 aggregation Effects 0.000 description 3
- 238000004220 aggregation Methods 0.000 description 3
- 235000021028 berry Nutrition 0.000 description 3
- 239000001390 capsicum minimum Substances 0.000 description 3
- 229940068682 chewable tablet Drugs 0.000 description 3
- 239000004310 lactic acid Substances 0.000 description 3
- 235000014655 lactic acid Nutrition 0.000 description 3
- 210000002414 leg Anatomy 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000012046 mixed solvent Substances 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 210000000689 upper leg Anatomy 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- 235000007862 Capsicum baccatum Nutrition 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 235000019510 Long pepper Nutrition 0.000 description 2
- 208000008589 Obesity Diseases 0.000 description 2
- 240000003455 Piper longum Species 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 235000009392 Vitis Nutrition 0.000 description 2
- 240000006365 Vitis vinifera Species 0.000 description 2
- 210000000577 adipose tissue Anatomy 0.000 description 2
- 210000003423 ankle Anatomy 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 159000000007 calcium salts Chemical class 0.000 description 2
- 244000309466 calf Species 0.000 description 2
- 239000001728 capsicum frutescens Substances 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 239000003797 essential amino acid Substances 0.000 description 2
- 235000020776 essential amino acid Nutrition 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 210000000245 forearm Anatomy 0.000 description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 235000020824 obesity Nutrition 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 239000007901 soft capsule Substances 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 2
- 238000012549 training Methods 0.000 description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 description 2
- 239000008158 vegetable oil Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- ALYNCZNDIQEVRV-UHFFFAOYSA-N 4-aminobenzoic acid Chemical compound NC1=CC=C(C(O)=O)C=C1 ALYNCZNDIQEVRV-UHFFFAOYSA-N 0.000 description 1
- IBFXLTFIVWRUQC-OVGYCKTGSA-N 9b,10b-epoxyroridin d Chemical compound C([C@@]12[C@]3(C)[C@H]4C[C@H]1OC1C5OC5(C)CCC13COC(=O)C1O[C@@]1(C)CCOC(\C=C\C=C/C(=O)O4)C(O)C)O2 IBFXLTFIVWRUQC-OVGYCKTGSA-N 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- 240000002900 Arthrospira platensis Species 0.000 description 1
- 235000016425 Arthrospira platensis Nutrition 0.000 description 1
- 240000006439 Aspergillus oryzae Species 0.000 description 1
- 235000002247 Aspergillus oryzae Nutrition 0.000 description 1
- 244000063299 Bacillus subtilis Species 0.000 description 1
- 235000014469 Bacillus subtilis Nutrition 0.000 description 1
- QQXDYWHKPKEBJU-UHFFFAOYSA-N CCCCCCCCCCCCCCCCCC[Na] Chemical compound CCCCCCCCCCCCCCCCCC[Na] QQXDYWHKPKEBJU-UHFFFAOYSA-N 0.000 description 1
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 1
- 235000002567 Capsicum annuum Nutrition 0.000 description 1
- 240000008384 Capsicum annuum var. annuum Species 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 241001672694 Citrus reticulata Species 0.000 description 1
- 240000000560 Citrus x paradisi Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 244000017020 Ipomoea batatas Species 0.000 description 1
- 235000002678 Ipomoea batatas Nutrition 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000001145 Metabolic Syndrome Diseases 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 235000011203 Origanum Nutrition 0.000 description 1
- 240000000783 Origanum majorana Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 1
- 241000208292 Solanaceae Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 241001512058 Vitis labrusca x Vitis vinifera Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- YKTSYUJCYHOUJP-UHFFFAOYSA-N [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] Chemical compound [O--].[Al+3].[Al+3].[O-][Si]([O-])([O-])[O-] YKTSYUJCYHOUJP-UHFFFAOYSA-N 0.000 description 1
- 210000000579 abdominal fat Anatomy 0.000 description 1
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- HZVVJJIYJKGMFL-UHFFFAOYSA-N almasilate Chemical compound O.[Mg+2].[Al+3].[Al+3].O[Si](O)=O.O[Si](O)=O HZVVJJIYJKGMFL-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 230000002429 anti-coagulating effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 210000000617 arm Anatomy 0.000 description 1
- 230000001174 ascending effect Effects 0.000 description 1
- 230000037147 athletic performance Effects 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 239000000378 calcium silicate Substances 0.000 description 1
- 229910052918 calcium silicate Inorganic materials 0.000 description 1
- WLJUMPWVUPNXMF-UHFFFAOYSA-L calcium;3-hydroxy-3-methylbutanoate Chemical compound [Ca+2].CC(C)(O)CC([O-])=O.CC(C)(O)CC([O-])=O WLJUMPWVUPNXMF-UHFFFAOYSA-L 0.000 description 1
- OYACROKNLOSFPA-UHFFFAOYSA-N calcium;dioxido(oxo)silane Chemical compound [Ca+2].[O-][Si]([O-])=O OYACROKNLOSFPA-UHFFFAOYSA-N 0.000 description 1
- 239000007894 caplet Substances 0.000 description 1
- 239000001511 capsicum annuum Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000001916 dieting Nutrition 0.000 description 1
- 230000037228 dieting effect Effects 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 210000001596 intra-abdominal fat Anatomy 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 150000002614 leucines Chemical class 0.000 description 1
- 230000003137 locomotive effect Effects 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- GUMSHIGGVOJLBP-SLRPQMTOSA-N methyl hesperidin Chemical compound C1=C(OC)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 GUMSHIGGVOJLBP-SLRPQMTOSA-N 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000011812 mixed powder Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 229940088417 precipitated calcium carbonate Drugs 0.000 description 1
- GCYXWQUSHADNBF-AAEALURTSA-N preproglucagon 78-108 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(=O)NCC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 GCYXWQUSHADNBF-AAEALURTSA-N 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000000284 resting effect Effects 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- IKGXIBQEEMLURG-NVPNHPEKSA-N rutin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-NVPNHPEKSA-N 0.000 description 1
- 208000001076 sarcopenia Diseases 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 229940082787 spirulina Drugs 0.000 description 1
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 210000004003 subcutaneous fat Anatomy 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229960003080 taurine Drugs 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 235000019871 vegetable fat Nutrition 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Images
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- General Preparation And Processing Of Foods (AREA)
Abstract
Description
[1]3-ヒドロキシ-3-メチル酪酸又はその塩と、ヒハツ及びヘスペリジンから選ばれる少なくとも1種の素材とを含有することを特徴とする経口組成物。
[2]さらに、ブドウ及びトウガラシから選ばれる少なくとも1種の素材を含有することを特徴とする上記[1]記載の経口組成物。
3-ヒドロキシ-3-メチル酪酸(HMB)とは、必須アミノ酸であるロイシンの代謝産物であり、ヒトの体内で合成される。本発明においては、HMB又はその塩が使用できる。HMBの塩としては、特に制限されないが、カルシウム塩、ナトリウム塩、カリウム塩、マグネシウム塩が挙げられ、筋肉増強効果やダイエット効果の観点から、カルシウム塩(HMBCa)が好ましい。本発明の経口組成物におけるHMB又はその塩は、公知の方法により合成したものや、市販品を用いることができる。市販品としては、食品に適用可能なものであれば限定されない。また、本発明においてHMB又はその塩は1種類のみを使用してもよいし、2種類以上を使用してもよい。
ヒハツとは、コショウ科コショウ属で、学名がPiper longum L.の植物で、別名のインドナガコショウで称されることもある。本発明で使用するヒハツとしては、成熟又は未成熟の果穂(実)、葉、葉柄、枝、根等が挙げられ、成熟又は未成熟の果穂が好ましい。ヒハツとしては、ヒハツを加工した加工物を用いてもよく、例えば、収穫したヒハツを乾燥させて粉砕し粉末にしたものや、水、低級アルコール又はそれらの混合溶媒等で抽出した抽出物(エキス末)や、発酵物(発酵粉末)を使用でき、エキス末を使用することが好ましい。本発明で使用するヒハツとしては、むくみ抑制効果やむくみ改善効果、身体の冷えの改善効果の観点から、成熟又は未成熟の果穂のエキス末が望ましい。
本発明で使用するヘスペリジンとしては、ヘスペリジン、又はこれを豊富に含む食品素材(例えば、みかん、グレープフルーツなどの柑橘類の果皮、果汁、種子の抽出物(エキス末))を挙げることができる。また、メチルヘスペリジン、酵素処理ヘスペリジン、糖転移ヘスペリジンなどのヘスペリジンの誘導体であってもよく、むくみ抑制効果やむくみ改善効果、血管の強化効果、血流改善効果の観点から、糖転移ヘスペリジンが好ましい。
ブドウは、ブドウ科に属する植物で、本発明で使用するブドウとしては、実、皮、種子、葉などを用いることができ、特に限定するものではないが、実、種子、又は葉が好ましい。また、ブドウとしては、欧米種(学名:Vitis. vinifera)、米国種(学名:Vitis. labrusca)など、特に限定するものではなく、いかなる品種を用いてもよいが、欧米種が好ましい。特に、赤色、紫色、青色、紺色又は黒色に近い果皮と赤色の果肉の欧米種である赤ブドウが好ましい。ブドウとしては、ブドウを加工した加工物を用いてもよく、例えば、収穫したブドウを乾燥させて粉砕し粉末にしたものや、水、低級アルコール又はそれらの混合溶媒等で抽出した抽出物(エキス末)や、発酵物(発酵粉末)を使用でき、エキス末を使用することが好ましい。本発明で使用するブドウとしては、むくみ抑制効果やむくみ改善効果、血小板凝集効果、抗炎症効果の観点から、ブドウの実、種子、又は葉のエキス末が好ましく、特に、赤ブドウの葉のエキス末が好ましい。また、3-ヒドロキシ-3-メチル酪酸又はその塩と、ヒハツ及びヘスペリジンから選ばれる少なくとも1種の素材とを含有する経口組成物に、ブドウ、特に、ブドウの実、種子、又は葉のエキス末、さらに好ましくは、赤ブドウの葉のエキス末を加えることで、むくみ抑制効果やむくみ改善効果の向上が期待できる。
トウガラシは、ナス科トウガラシ属で、学名がCapsicum annuumの植物で、本発明で使用するトウガラシとしては、実や葉などを用いることができ、特に限定するものではないが、実が好ましい。また、トウガラシとしては、実が熟し、赤色をした、いわゆる赤トウガラシ、実が未成熟で、緑色をした、いわゆる青トウガラシなどいずれのトウガラシを用いてもよいが、青トウガラシを用いることが好ましい。また、トウガラシとしては、トウガラシを加工した加工物を用いてもよく、例えば、収穫したトウガラシを乾燥させて粉砕し粉末にしたものや、水、低級アルコール又はそれらの混合溶媒等で抽出した抽出物(エキス末)や、発酵物(発酵粉末)を使用でき、発酵粉末を使用することが好ましい。
3-ヒドロキシ-3-メチル酪酸又はその塩としては、HMBCa(粉末)を用いた。
ヒハツとしては、ヒハツの果穂を熱水で抽出したものを乾燥し、粉砕したエキス末を用いた。
ヘスペリジンとしては、糖転移ヘスペリジンを用いた。
ブドウとしては、赤ブドウの葉を30%エタノール水溶液で抽出したものを乾燥し、粉砕したエキス末を用いた。
トウガラシとしては、青トウガラシの実を、乳酸菌を用いて発酵し、固液分離によって液体を得て、デキストリンを添加・混合し、スプレードライして粉末にした発酵抽出物(粉末)を用いた。
その結果を表2及び図1に示す。
下記表3の配合にて、HMB又はその塩と、ヒハツ及び/又はヘスペリジンを含有する顆粒剤を製造した。
下記表4の配合にて、HMB又はその塩と、ヒハツ及び/又はヘスペリジンを含有する顆粒剤を製造した。
下記表5の配合にて、HMB又はその塩と、ヒハツ及び/又はヘスペリジンを含有する粉末飲料を製造した。
下記表6の配合にて、HMB又はその塩と、ヒハツ及び/又はヘスペリジンを含有するソフトカプセルを製造した。
下記表7の配合にて、HMB又はその塩と、ヒハツ及び/又はヘスペリジンを含有するハードカプセルを製造した。
下記表8の配合にて、HMB又はその塩と、ヒハツ及び/又はヘスペリジンを含有する液体飲料を製造した。
下記表9の配合にて、HMB又はその塩と、ヒハツ及び/又はヘスペリジンを含有する錠剤を製造した。
Claims (2)
- 3-ヒドロキシ-3-メチル酪酸又はその塩と、ヘスペリジンと、ブドウ又はトウガラシから選ばれる少なくとも1種の素材とを含有することを特徴とする経口組成物。
- 3-ヒドロキシ-3-メチル酪酸又はその塩と、ヘスペリジンとを含有することを特徴とする経口組成物(ただし、ブラックジンジャーを含有する経口組成物を除く)。
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2022153423A JP7586513B2 (ja) | 2018-09-28 | 2022-09-27 | 経口組成物 |
JP2024190565A JP2025003735A (ja) | 2018-09-28 | 2024-10-30 | 経口組成物 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018183344A JP7156683B2 (ja) | 2018-09-28 | 2018-09-28 | 経口組成物 |
JP2022153423A JP7586513B2 (ja) | 2018-09-28 | 2022-09-27 | 経口組成物 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2018183344A Division JP7156683B2 (ja) | 2018-09-28 | 2018-09-28 | 経口組成物 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2024190565A Division JP2025003735A (ja) | 2018-09-28 | 2024-10-30 | 経口組成物 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2022173374A true JP2022173374A (ja) | 2022-11-18 |
JP7586513B2 JP7586513B2 (ja) | 2024-11-19 |
Family
ID=69995777
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2018183344A Active JP7156683B2 (ja) | 2018-09-28 | 2018-09-28 | 経口組成物 |
JP2022153423A Active JP7586513B2 (ja) | 2018-09-28 | 2022-09-27 | 経口組成物 |
JP2024190565A Pending JP2025003735A (ja) | 2018-09-28 | 2024-10-30 | 経口組成物 |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2018183344A Active JP7156683B2 (ja) | 2018-09-28 | 2018-09-28 | 経口組成物 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2024190565A Pending JP2025003735A (ja) | 2018-09-28 | 2024-10-30 | 経口組成物 |
Country Status (1)
Country | Link |
---|---|
JP (3) | JP7156683B2 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2023141408A1 (en) * | 2022-01-21 | 2023-07-27 | Abbott Laboratories | Beta-hydroxy beta-methylbutyrate and a citrus flavonoid for promoting muscle regeneration |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009520029A (ja) * | 2005-12-19 | 2009-05-21 | アボット・ラボラトリーズ | 1型および2型サイトカイン産生における不均衡を調節するためのベータ−ヒドロキシ−ベータ−メチルブチラートの使用 |
JP2018091750A (ja) * | 2016-12-05 | 2018-06-14 | 小林香料株式会社 | Hmbの測定方法 |
CN108558641A (zh) * | 2018-05-15 | 2018-09-21 | 江苏玺鑫维生素有限公司 | 一种β-羟基-β-甲基丁酸钙的制备及纯化方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2007259827A (ja) | 2006-03-30 | 2007-10-11 | Q P Corp | 粉末状或いは顆粒状の飲料 |
WO2012012844A1 (en) | 2010-07-29 | 2012-02-02 | The University Of Sydney | Vegetable and fruit juice powder |
CA3120969A1 (en) * | 2012-01-26 | 2013-08-01 | Incredible Foods, Inc. | Enclosing materials in natural transport systems |
JP2013233119A (ja) | 2012-05-10 | 2013-11-21 | Nikken Foods Co Ltd | 果汁由来固形分高含有果汁粉末の製造法 |
WO2017047706A1 (ja) | 2015-09-18 | 2017-03-23 | 株式会社林原 | 血糖値上昇抑制剤及びこれを含んでなる経口組成物 |
-
2018
- 2018-09-28 JP JP2018183344A patent/JP7156683B2/ja active Active
-
2022
- 2022-09-27 JP JP2022153423A patent/JP7586513B2/ja active Active
-
2024
- 2024-10-30 JP JP2024190565A patent/JP2025003735A/ja active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2009520029A (ja) * | 2005-12-19 | 2009-05-21 | アボット・ラボラトリーズ | 1型および2型サイトカイン産生における不均衡を調節するためのベータ−ヒドロキシ−ベータ−メチルブチラートの使用 |
JP2018091750A (ja) * | 2016-12-05 | 2018-06-14 | 小林香料株式会社 | Hmbの測定方法 |
CN108558641A (zh) * | 2018-05-15 | 2018-09-21 | 江苏玺鑫维生素有限公司 | 一种β-羟基-β-甲基丁酸钙的制备及纯化方法 |
Non-Patent Citations (7)
Title |
---|
"スイートスプリング用途拡大に向けた取り組み(2)", 研究報告, vol. 12号, JPN6023033494, 2012, pages 99 - 101, ISSN: 0005129225 * |
(FIJI)イカバカミティ BY もんのすけ食堂 [クックパッド] 簡単おいしいみんなのレシピが386万品, JPN6023033490, 2012, ISSN: 0005129221 * |
J APPL PHYSIOL, vol. 81, JPN6023033495, 1996, pages 2095 - 2104, ISSN: 0005129227 * |
NUTRITION AND ENHANCED SPORTS PERFORMANCE, JPN6023033493, 2013, pages 455 - 463, ISSN: 0005129224 * |
フルーツ入り ♪リボンパスタのサラダ ♪ BY ごん太はな [クックパッド] 簡単おいしいみんなのレシピが38, JPN6023033491, 2014, ISSN: 0005129222 * |
日本食生活学会誌, vol. 26, no. 2, JPN6022016255, 2015, pages 71 - 78, ISSN: 0005129226 * |
赤!SPICY BBEEF BY KBITCH [クックパッド] 簡単おいしいみんなのレシピが386万品, JPN6023033492, 2015, ISSN: 0005129223 * |
Also Published As
Publication number | Publication date |
---|---|
JP7586513B2 (ja) | 2024-11-19 |
JP2025003735A (ja) | 2025-01-09 |
JP7156683B2 (ja) | 2022-10-19 |
JP2020050631A (ja) | 2020-04-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP7373869B2 (ja) | 経口組成物 | |
JP2025003735A (ja) | 経口組成物 | |
TWI225789B (en) | Compositions inhibiting muscle atrophy | |
JP2024138133A (ja) | 経口組成物 | |
JP2019034896A (ja) | 経口組成物 | |
JP7117763B2 (ja) | 経口組成物 | |
JP6841444B2 (ja) | 免疫賦活剤 | |
JP6541047B1 (ja) | 経口組成物 | |
JP6838752B2 (ja) | 血流改善組成物 | |
JP2016027042A (ja) | Glp−1産生促進剤、dppiv阻害剤及びグルコース吸収阻害剤 | |
JP6883364B1 (ja) | 経口組成物、筋肉増強用組成物並びに抗肥満用組成物 | |
JP7385256B2 (ja) | 経口組成物 | |
JP7527032B2 (ja) | 経口組成物 | |
JP2023063521A (ja) | 経口組成物 | |
JP7401082B2 (ja) | 経口組成物 | |
JP2021066739A (ja) | 血流改善組成物 | |
JP2020195286A (ja) | 経口組成物 | |
JP2023170690A (ja) | 経口組成物 | |
JP4902349B2 (ja) | 筋ジストロフィー進行抑制組成物 | |
JP2022095986A (ja) | 経口組成物 | |
JP2020138936A (ja) | 経口組成物 | |
JP2020191902A (ja) | 経口組成物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20220929 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20230815 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20231013 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20231213 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240220 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240415 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20240521 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20240712 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20241001 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20241030 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 7586513 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |